Relationship between dopamine and iron contents in the brain of Parkinsonian rats

( views:, downloads: )
Journal Title:
Volume 53, Issue 05, 2001
Key Word:


  • [1]Mitzuno Y,Mori H,Kondo T.Potential of neuroprotective therapy in Parkinson′s disease.CNS Drug,1994,1:45~56.
  • [2]Marx JJ,Van Asbeck BS.Use of iron chelators in preventing hydroxyl radical damage:adult respiratory distress syndrome as an experimental model for the pathophysiology and treatmeat of oxygen-radical-mediated-tissue damage.Acta Haematol,1996,95:49~62.
  • [3]Jellinger K,Paulu W,Grundke-Iqbal I et al.Brain iron and ferritin in Parkinson′s and Alzheimer′s diseases.J Neural Transm,1990; (PD sect)2:237~340.
  • [4]Sofic E,Paulus W,Jellinger K et al.Selective increase of iron in substantia nigra zona compacta of parkinsonian brains.J Neurochem,1991,56:978~982.
  • [5]Youdim MBH,Ben-Shachar D,Riedeerer P.The possible of iron in etiopathology of Parkinson′s disease.Mov Disord,1993,8:1~12.
  • [6]Paxins G,Watson C (eds).The Rat Brain in Stereotaxic Coordinates.London:Academic Press,1986,1~104.
  • [7]Earl CD,Reum T,Xie JX et al.Foetal nigral cell suspension grafts influence dopamine release in the non-grafted side in the 6-OHDA rat model of Parkinson′s disease:in vivo voltammetric data.Exp Brain Res,1996,109:179~184.
  • [8]Xie JX (谢俊霞),Tang M (唐明).Effects of electrical stimulation of the dopaminergic nerve fiber or nerve terminal on striatal dopamine release in the rat.Chin J Neurosci (中国神经科学杂志),1999,15(1):20~26 (Chinese,with English abstract).
  • [9]Xie JX (谢俊霞),Zhou Y(周宇),Jiang H (姜宏).Monitoring dopamine release by fast cyclic voltammetry:an in vivo study.Chin J Appl Physiol (中国应用生理学杂志),2000,16(3):109~113 (Chinese,with English abstract).
  • [10]Xie JX (谢俊霞),Liu B (刘彬).Effect of estrogen on dopamine release evoked by electric stimulation of central amygdaloid nucleus.Acta Physiol Sin (生理学报),2001,53(3):170~174 (Chinese,with English abstract).
  • [11]Lucien C,Michael DC.The Basal Ganglia.In:Eric RK ed.Principles of Neural Science.New York:Appleton & Larce,1991,647~659.
  • [12]Kienzl E,Jellinger K,Stachelberger H et al.Iron as catalyst for oxidative stress in the pathogenesis of Parkinson′s disease? Life Sci,1999,65:1973~1976.
  • [13]Borisenko GG,Kagan V,Hsia CJ et al.Interaction between 6-hydroxydopamine and transferrin:"let my iron go”.Biochemistry,2000,39(12):3392~3400.
  • [14]Glinka Y,Gassen M,Youdim MB.Mechanism of 6-hydroxydopamine neurotoxicity.J Neural Transm,1997,50 (Suppl):55~66.
  • [15]Youdim MBH,Ben-Shachar D,Riederer P.Is Parkinson′s disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeration? Acta Neuro Scand,1989,126:47~54.
  • [16]Venarucci D,Venarucci V,Vallese A et al.Free radicals:important cause of pathologies refer to aging.Panminerva Med,1999,41(4):335~339.
  • [17]Minotti G,Aust SD.The requirement for iron (Ⅲ) in the initiation of lipid peroxidation by iron (Ⅱ) and hydrogen peroxide.J Biol Chem,1987,262:1098~1104.
  • [18]Youdim MBH,Ben-Shachar D,Riederer P.The role of mo~no~amine oxidase,iron-melanin interaction,and intracellular calcium in Parkinson′s disease.J Neural Transm,1990,32(suppl):239~248.
  • [19]Riederer P,Youdim MBH (eds).Iron in Central Nervous System Disorders.New York:Springer,1993,87~101.
  • [20]Glinka Y,Tipton KF,Youdim MBH.Nature of inhibiton of mitochondrial respiratory complex Ⅰ by 6-hydroxydopamine.J Neurochem,1996,66:2004~2010.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615